TherapeuticsMD | TXMD - Current Assets

Stock Price
2.33
Daily Change
0.04 1.53%
Monthly
2.88%
Yearly
130.20%
Q1 Forecast
2.17

TherapeuticsMD reported $11.82M in Current Assets for its fiscal quarter ending in June of 2024.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Alterity Therapeutics Limited AUD 27.05M 6.16M Jun/2023
Cipla INR 249.18B 16.3B Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Grifols EUR 5.96B 316.31M Dec/2025
Novo Nordisk DKK 25.71B 148.69B Jun/2025
Pfizer USD 46.92B 3.22B Sep/2025
TherapeuticsMD USD 11.82M 303K Jun/2024